JP2023515469A5 - - Google Patents

Info

Publication number
JP2023515469A5
JP2023515469A5 JP2022549809A JP2022549809A JP2023515469A5 JP 2023515469 A5 JP2023515469 A5 JP 2023515469A5 JP 2022549809 A JP2022549809 A JP 2022549809A JP 2022549809 A JP2022549809 A JP 2022549809A JP 2023515469 A5 JP2023515469 A5 JP 2023515469A5
Authority
JP
Japan
Prior art keywords
sequence
integer
range
fusion protein
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022549809A
Other languages
English (en)
Japanese (ja)
Other versions
JP7904131B2 (ja
JP2023515469A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/018812 external-priority patent/WO2021168276A1/en
Publication of JP2023515469A publication Critical patent/JP2023515469A/ja
Publication of JP2023515469A5 publication Critical patent/JP2023515469A5/ja
Priority to JP2026066148A priority Critical patent/JP2026123027A/ja
Application granted granted Critical
Publication of JP7904131B2 publication Critical patent/JP7904131B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022549809A 2020-02-19 2021-02-19 Aav結合ポリペプチドを含む精製マトリックス及びその使用方法 Active JP7904131B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026066148A JP2026123027A (ja) 2020-02-19 2026-04-14 Aav結合ポリペプチドを含む精製マトリックス及びその使用方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202062978616P 2020-02-19 2020-02-19
US62/978,616 2020-02-19
US202063081405P 2020-09-22 2020-09-22
US63/081,405 2020-09-22
PCT/US2021/018812 WO2021168276A1 (en) 2020-02-19 2021-02-19 Purification matrices comprising aav-binding polypeptides and methods of using the same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026066148A Division JP2026123027A (ja) 2020-02-19 2026-04-14 Aav結合ポリペプチドを含む精製マトリックス及びその使用方法

Publications (3)

Publication Number Publication Date
JP2023515469A JP2023515469A (ja) 2023-04-13
JP2023515469A5 true JP2023515469A5 (cg-RX-API-DMAC10.html) 2024-02-29
JP7904131B2 JP7904131B2 (ja) 2026-08-12

Family

ID=77391789

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022549809A Active JP7904131B2 (ja) 2020-02-19 2021-02-19 Aav結合ポリペプチドを含む精製マトリックス及びその使用方法
JP2026066148A Pending JP2026123027A (ja) 2020-02-19 2026-04-14 Aav結合ポリペプチドを含む精製マトリックス及びその使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026066148A Pending JP2026123027A (ja) 2020-02-19 2026-04-14 Aav結合ポリペプチドを含む精製マトリックス及びその使用方法

Country Status (5)

Country Link
US (1) US12637664B2 (cg-RX-API-DMAC10.html)
EP (1) EP4107268A4 (cg-RX-API-DMAC10.html)
JP (2) JP7904131B2 (cg-RX-API-DMAC10.html)
AU (1) AU2021224766A1 (cg-RX-API-DMAC10.html)
WO (1) WO2021168276A1 (cg-RX-API-DMAC10.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12269847B2 (en) 2018-08-16 2025-04-08 Donaldson Company, Inc. Genetically encoded polypeptide for affinity capture and purification of biologics
US12692483B2 (en) 2020-02-19 2026-07-28 Donaldson Company, Inc. Protein-based purification matrices and methods of using the same
EP4107268A4 (en) 2020-02-19 2024-03-27 Donaldson Company, Inc. PURIFICATION MATRICES COMPRISING VAA-BINDING POLYPEPTIDES AND METHODS OF USE THEREOF
US20220009961A1 (en) * 2020-07-09 2022-01-13 Waters Technologies Corporation Compositions, kits and methods useful for separating proteins from surfactants
JP2023545375A (ja) * 2020-10-13 2023-10-30 アヴィタイド エルエルシー Aav8親和剤
US20250002938A1 (en) * 2021-11-09 2025-01-02 The Francis Crick Institute Limited Viral adaptors and uses thereof
JP7896322B2 (ja) * 2021-11-29 2026-07-29 東ソー株式会社 キメラアデノ随伴ウイルスの分析方法
US20250236657A1 (en) * 2022-01-21 2025-07-24 Tosoh Corporation Modified recombinant adeno-associated virus (aav)-binding protein, and method for analyzing aav based on infectivity
AU2023307957A1 (en) * 2022-07-12 2025-01-09 Donaldson Company, Inc. Compositions and methods for improving viral transduction
WO2024100450A2 (en) * 2022-11-07 2024-05-16 Vectory B.V. Peptides for affinity purification of adeno-associated virus
WO2026011071A1 (en) * 2024-07-03 2026-01-08 Donaldson Company, Inc. Viral transduction reagents and methods of use

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5354844A (en) 1989-03-16 1994-10-11 Boehringer Ingelheim International Gmbh Protein-polycation conjugates
US5283173A (en) 1990-01-24 1994-02-01 The Research Foundation Of State University Of New York System to detect protein-protein interactions
US5496926A (en) 1992-01-19 1996-03-05 Yeda Research And Development Co. Ltd. Process of preparing a soluble LDL receptor
US6410300B1 (en) * 1998-01-12 2002-06-25 The University Of North Carolina At Chapel Hill Methods and formulations for mediating adeno-associated virus (AAV) attachment and infection and methods for purifying AAV
WO2000056774A1 (en) 1999-03-19 2000-09-28 Duke University Methods of using bioelastomers
US6852834B2 (en) 2000-03-20 2005-02-08 Ashutosh Chilkoti Fusion peptides isolatable by phase transition
US20050255554A1 (en) 2000-03-20 2005-11-17 Ashutosh Chilkoti Fusion peptides isolatable by phase transition
AU2001270215A1 (en) 2000-06-27 2002-01-08 Curagen Corporation Novel polynucleotides and polypeptides encoded thereby
US20030194704A1 (en) 2002-04-03 2003-10-16 Penn Sharron Gaynor Human genome-derived single exon nucleic acid probes useful for gene expression analysis two
JP4559429B2 (ja) 2003-05-21 2010-10-06 ジェンザイム・コーポレーション 空キャプシドを実質的に含まない組換えaavビリオン調製物を生成するための方法
WO2006110292A2 (en) 2005-03-25 2006-10-19 The Regents Of The University Of California Temperature-triggered immobilization and purification of antibodies
US8673848B2 (en) 2012-01-27 2014-03-18 Novartis Ag Synthetic apelin mimetics for the treatment of heart failure
CN101528916B (zh) 2006-04-28 2013-09-04 宾夕法尼亚大学托管会 规模可调的aav生产方法
CN101578373A (zh) 2006-09-06 2009-11-11 费斯生物制药公司 融合肽治疗组合物
US8470967B2 (en) 2010-09-24 2013-06-25 Duke University Phase transition biopolymers and methods of use
US8609621B2 (en) 2010-11-15 2013-12-17 E I Du Pont De Nemours And Company Acid-cleavable linkers exhibiting altered rates of acid hydrolysis
US20140088019A1 (en) 2011-02-11 2014-03-27 Zyngenia, Inc. Monovalent and Multivalent Multispecific Complexes and Uses Thereof
EP2668962B1 (en) 2012-05-29 2016-10-26 Albert-Ludwigs-Universität Freiburg Protein assembler
US20150218280A1 (en) 2012-08-10 2015-08-06 University Of Southern California CD20 scFv-ELPs METHODS AND THERAPEUTICS
WO2014145654A1 (en) 2013-03-15 2014-09-18 The Trustees Of The University Of Pennsylvania Method for the site-specific covalent cross-linking of antibodies to surfaces
US9616138B1 (en) 2013-09-26 2017-04-11 University Of South Florida Cargo carrying nanoparticles
KR20160067219A (ko) 2013-10-03 2016-06-13 모더나 세라퓨틱스, 인코포레이티드 저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드
WO2015130846A2 (en) 2014-02-25 2015-09-03 Duke University Compositions and methods for the site-specific modification of polypeptides
EP3054007A1 (en) 2015-02-09 2016-08-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Recombinant adeno-associated virus particle purification comprising an immuno-affinity purification step
CN104725515B (zh) * 2015-03-20 2017-11-14 扬州大学 一种类弹性蛋白多肽与柯萨奇腺病毒受体融合蛋白及其制备方法和应用
WO2016154530A1 (en) 2015-03-26 2016-09-29 Duke University Targeted therapeutic agents comprising multivalent protein-biopolymer fusions
CN105175554B (zh) 2015-10-26 2018-09-25 扬州大学 一种类弹性蛋白多肽与热应激蛋白90α融合蛋白及其制备方法和应用
US10633662B2 (en) * 2015-11-10 2020-04-28 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for modulating AAV infection
US11015174B2 (en) 2015-12-11 2021-05-25 The Trustees Of The University Of Pennsylvania Scalable purification method for AAV8
US11149060B2 (en) 2016-02-19 2021-10-19 University Of Delaware Functionalized nanoparticles for enhanced affinity precipitation of proteins
KR20190064600A (ko) 2016-09-23 2019-06-10 듀크 유니버시티 Lcst 거동을 갖는 비구조화된 비-반복적 폴리펩티드
US11648200B2 (en) * 2017-01-12 2023-05-16 Duke University Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature triggered hierarchical self-assembly
US11464867B2 (en) 2018-02-13 2022-10-11 University Of Southern California Multimeric elastin-like polypeptides
CA3098565A1 (en) 2018-04-29 2019-11-07 Claire G. ZHANG Scalable clarification process for recombinant aav production
US12269847B2 (en) 2018-08-16 2025-04-08 Donaldson Company, Inc. Genetically encoded polypeptide for affinity capture and purification of biologics
US20220402995A1 (en) 2019-11-25 2022-12-22 Tosoh Corporation Improved adeno-associated virus-binding protein, method for producing same, and adeno-associated virus adsorbent using same
EP4107268A4 (en) 2020-02-19 2024-03-27 Donaldson Company, Inc. PURIFICATION MATRICES COMPRISING VAA-BINDING POLYPEPTIDES AND METHODS OF USE THEREOF
US12692483B2 (en) 2020-02-19 2026-07-28 Donaldson Company, Inc. Protein-based purification matrices and methods of using the same
EP4107167A4 (en) 2020-02-19 2024-04-03 Donaldson Company, Inc. PROTEIN-BASED PURIFICATION MATRIX AND METHODS OF USE
JP7795205B2 (ja) 2020-03-04 2026-01-07 デューク ユニバーシティ タンパク質ナノ粒子の設計および適用
AU2021231786A1 (en) 2020-03-04 2022-09-08 Duke University Proteins with predictable liquid-liquid phase separation
CN117279936A (zh) 2021-02-19 2023-12-22 唐纳森公司 包含具有相行为的蛋白的融合蛋白
WO2023212694A2 (en) 2022-04-29 2023-11-02 Donaldson Company, Inc. Compositions comprising aav-binding polypeptides and methods of using the same
AU2023307957A1 (en) 2022-07-12 2025-01-09 Donaldson Company, Inc. Compositions and methods for improving viral transduction
US20250066759A1 (en) 2023-08-24 2025-02-27 Donaldson Company, Inc. Fusion proteins for purifying nucleic acids

Similar Documents

Publication Publication Date Title
JP2023514611A5 (cg-RX-API-DMAC10.html)
US11591576B2 (en) Protein-based purification matrices and methods of using the same
US20230348863A1 (en) Purification matrices comprising aav-binding polypeptides and methods of using the same
KR20210020100A (ko) 재조합 aav 생성을 위한 음이온 교환 크로마토그래피
JP2003505033A5 (cg-RX-API-DMAC10.html)
CA2379564A1 (en) Structural protein of adeno-associated virus with modified chromatographic properties, its production and use
JP2020505936A5 (cg-RX-API-DMAC10.html)
JP2022523679A5 (cg-RX-API-DMAC10.html)
US20230340426A1 (en) Protein-based purification matrices and methods of using the same
CA2329060A1 (en) Aav5 vector and uses thereof
Arai et al. Glutamyl oligopeptides as factors responsible for tastes of a proteinase-modified soybean protein
Castro-Muñoz et al. Current evidence in high throughput ultrafiltration toward the purification of monoclonal antibodies (mAbs) and biotechnological protein-type molecules
CN111808828B (zh) 腺相关病毒的分离纯化方法
WO2022038164A1 (en) Multimodal metal affinity processing aav capsids
CN111925438A (zh) 能够与aav1-13结合的抗体
US20260070942A1 (en) Reuse of intein-bound resins for protein purification
CN1473067A (zh) 综合分离方法
CN115651081A (zh) 一种破伤风抗毒素的纯化方法、层析填料及破伤风抗毒素
Galier et al. Electrophoretic membrane contactors
CA2196368A1 (en) Fibrinogen binding peptides
US20240124892A1 (en) Adeno-associated viruses and methods and materials for making and using adeno-associated viruses
GB2643811A (en) Compositions and methods for purifying viral vectors
JP7823448B2 (ja) アデノ随伴ウイルス結合性タンパク質の安定化法
Hjertén Fractionation of membrane proteins by hydrophobic interaction chromatography and by chromatography on agarose equilibrated with a water-alcohol mixture of low or high pH
US20030047455A1 (en) Separation of components from milk sources